These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 15960573)

  • 1. A preliminary study of luteal phase versus symptom-onset dosing with escitalopram for premenstrual dysphoric disorder.
    Freeman EW; Sondheimer SJ; Sammel MD; Ferdousi T; Lin H
    J Clin Psychiatry; 2005 Jun; 66(6):769-73. PubMed ID: 15960573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid response to fluoxetine in women with premenstrual dysphoric disorder.
    Steinberg EM; Cardoso GM; Martinez PE; Rubinow DR; Schmidt PJ
    Depress Anxiety; 2012 Jun; 29(6):531-40. PubMed ID: 22565858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Symptom-Onset Treatment With Sertraline Improve Functional Impairment for Individuals With Premenstrual Dysphoric Disorder?: A Randomized Controlled Trial.
    Yonkers KA; Altemus M; Gilstad-Hayden K; Kornstein SG; Gueorguieva R
    J Clin Psychopharmacol; 2023 Jul-Aug 01; 43(4):320-325. PubMed ID: 37212651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated gray matter volume of the emotional cerebellum in women with premenstrual dysphoric disorder.
    Berman SM; London ED; Morgan M; Rapkin AJ
    J Affect Disord; 2013 Apr; 146(2):266-71. PubMed ID: 22868063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting response to leuprolide of women with premenstrual dysphoric disorder by daily mood rating dynamics.
    Pincus SM; Alam S; Rubinow DR; Bhuvaneswar CG; Schmidt PJ
    J Psychiatr Res; 2011 Mar; 45(3):386-94. PubMed ID: 20708199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premenstrual dysphoria and luteal stress in dominant-social-status female macaques.
    Qiao M; Zhao Q; Wei S; Zhang H; Wang H
    Evid Based Complement Alternat Med; 2013; 2013():393862. PubMed ID: 24371458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Combined Use of Calcium and Vitamin B6 on Premenstrual Syndrome Symptoms: a Randomized Clinical Trial.
    Masoumi SZ; Ataollahi M; Oshvandi K
    J Caring Sci; 2016 Mar; 5(1):67-73. PubMed ID: 26989667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escitalopram administered in the luteal phase exerts a marked and dose-dependent effect in premenstrual dysphoric disorder.
    Eriksson E; Ekman A; Sinclair S; Sörvik K; Ysander C; Mattson UB; Nissbrandt H
    J Clin Psychopharmacol; 2008 Apr; 28(2):195-202. PubMed ID: 18344730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies.
    Kornstein SG; Pearlstein TB; Fayyad R; Farfel GM; Gillespie JA
    J Clin Psychiatry; 2006 Oct; 67(10):1624-32. PubMed ID: 17107257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premenstrual syndrome: new insights into etiology and review of treatment methods.
    Modzelewski S; Oracz A; Żukow X; Iłendo K; Śledzikowka Z; Waszkiewicz N
    Front Psychiatry; 2024; 15():1363875. PubMed ID: 38716118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Premenstrual Dysphoric Disorder: A Scoping Review.
    Carlini SV; Lanza di Scalea T; McNally ST; Lester J; Deligiannidis KM
    Int J Womens Health; 2022; 14():1783-1801. PubMed ID: 36575726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient Experiences of Health Care Providers in Premenstrual Dysphoric Disorder: Examining the Role of Provider Specialty.
    Hantsoo L; Sajid H; Murphy L; Buchert B; Barone J; Raja S; Eisenlohr-Moul T
    J Womens Health (Larchmt); 2022 Jan; 31(1):100-109. PubMed ID: 33978482
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence-Based Treatment of Premenstrual Dysphoric Disorder: A Concise Review.
    Carlini SV; Deligiannidis KM
    J Clin Psychiatry; 2020 Feb; 81(2):. PubMed ID: 32023366
    [No Abstract]   [Full Text] [Related]  

  • 14. Premenstrual dysphoric disorder: General overview, treatment strategies, and focus on sertraline for symptom-onset dosing.
    Andrade C
    Indian J Psychiatry; 2016; 58(3):329-331. PubMed ID: 28066013
    [No Abstract]   [Full Text] [Related]  

  • 15. Premenstrual Dysphoric Disorder: Epidemiology and Treatment.
    Hantsoo L; Epperson CN
    Curr Psychiatry Rep; 2015 Nov; 17(11):87. PubMed ID: 26377947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial.
    Yonkers KA; Kornstein SG; Gueorguieva R; Merry B; Van Steenburgh K; Altemus M
    JAMA Psychiatry; 2015 Oct; 72(10):1037-44. PubMed ID: 26351969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective serotonin reuptake inhibitors for premenstrual syndrome.
    Marjoribanks J; Brown J; O'Brien PM; Wyatt K
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001396. PubMed ID: 23744611
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.